Clinical applications of population pharmacokinetic models of antibiotics: challenges and perspectives F de Velde, JW Mouton, BCM de Winter, T van Gelder, BCP Koch Pharmacological research 134, 280-288, 2018 | 152 | 2018 |
Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints F de Velde, BCM de Winter, BCP Koch, T van Gelder, JW Mouton Journal of Antimicrobial Chemotherapy 71 (10), 2909-2917, 2016 | 94 | 2016 |
Simultaneous determination of clarithromycin, rifampicin and their main metabolites in human plasma by liquid chromatography–tandem mass spectrometry F de Velde, JWC Alffenaar, AMA Wessels, B Greijdanus, DRA Uges Journal of Chromatography B 877 (18-19), 1771-1777, 2009 | 81 | 2009 |
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection JWC Alffenaar, WA Nienhuis, F De Velde, AT Zuur, AMA Wessels, ... Antimicrobial agents and chemotherapy 54 (9), 3878-3883, 2010 | 69 | 2010 |
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net MEA de Kraker, H Sommer, F de Velde, I Gravestock, E Weiss, ... Clinical Infectious Diseases 67 (12), 1922-1931, 2018 | 36 | 2018 |
Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis F De Velde, BCM De Winter, BCP Koch, T Van Gelder, JW Mouton, ... Journal of Antimicrobial Chemotherapy 73 (2), 469-476, 2018 | 20 | 2018 |
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an … F de Velde, BCM de Winter, MN Neely, WM Yamada, BCP Koch, ... Clinical Pharmacokinetics, 1-14, 2020 | 14 | 2020 |
High tobramycin serum concentrations after tobramycin inhalation in a child with renal failure F de Velde, M Emonts, S Verbruggen, H van der Sijs Journal of Antimicrobial Chemotherapy 69 (11), 3163-3164, 2014 | 11 | 2014 |
Dosing Optimization of Beta-Lactam Antibiotics using Parametric and Nonparametric Population Pharmacokinetic Models F de Velde | 1 | 2020 |